TRANSDERMAL ADJUVANT ADMINISTRATION OF PEPTIDE-BASED VACCINE, HIGH-RISK MELANOMA
TRANSDERMAL ADJUVANT ADMINISTRATION OF PEPTIDE-BASED VACCINE, HIGH-RISK MELANOMA
批准号:
7606692
负责人:
Craig Lee Slingluff
金额:
$2.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2008-02-29
关键词:
AdjuvantComputer Retrieval of Information on Scientific Projects DatabaseEnd PointFundingGrantInstitutionLangerhans cellMHC Class I GenesMeasuresPatientsPeptidesResearchResearch PersonnelResourcesRiskSafetySerumSkinSourceUnited States National Institutes of Healthcytokineimmunogenicitymelanomapeptide based vaccine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This study will evaluate the safety and immunogenicity of twelve class I MHC-restricted melanoma-associated peptides when administered transdermally in different adjuvants to patients with advanced melanoma. As secondary endpoints, we will evaluate the recruitment and maturation of Langerhans cells in the skin and measure changes in serum cytokine levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibodies to melanoma vaccine peptides
-
批准号:9378813
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2017
-
负责人:Craig Lee Slingluff
-
依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
-
批准号:9295843
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2013
-
负责人:Craig Lee Slingluff
-
依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
-
批准号:8692713
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2013
-
负责人:Craig Lee Slingluff
-
依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
-
批准号:8561255
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2013
-
负责人:Craig Lee Slingluff
-
依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
-
批准号:8915646
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2013
-
负责人:Craig Lee Slingluff
-
依托单位:
PHASE 2: CCI-779 IN COMBINATION WITH BEVACIZUMAB IN STAGE III OR IV MELANOMA
-
批准号:8167165
-
项目类别:
-
资助金额:$4.41万
-
财政年份:2010
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: A PHASE II TRIAL OF VACCINATION WITH PEPTIDES FOR PATIENTS WITH
-
批准号:8167154
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2010
-
负责人:Craig Lee Slingluff
-
依托单位:
A MULTIPEPTIDE VACCINE IN MELANOMA PATIENTS WITH EVALUATION OF INJECTION SITE
-
批准号:8167189
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2010
-
负责人:Craig Lee Slingluff
-
依托单位:
INTRATUMORAL INTERFERON GAMMA DURING VACCINATION IN METASTATIC MELANOMA
-
批准号:8167196
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2010
-
负责人:Craig Lee Slingluff
-
依托单位:
Melanoma vaccines using MHC-associated peptides
-
批准号:7913480
-
项目类别:
-
资助金额:$7.54万
-
财政年份:2009
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: A PHASE II TRIAL OF VACCINATION WITH PEPTIDES FOR PATIENTS WITH
-
批准号:7951467
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2009
-
负责人:Craig Lee Slingluff
-
依托单位:
A MULTIPEPTIDE VACCINE IN MELANOMA PATIENTS WITH EVALUATION OF INJECTION SITE
-
批准号:7951515
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2009
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: PHASE 2: CCI-779 IN COMBINATION WITH BEVACIZUMAB IN STAGE III OR
-
批准号:7951485
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2009
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: EVALUATION OF CYCLOPHOSPHAMIDE WITH PEPTIDE VACCINES IN PARTICIP
-
批准号:7951465
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2009
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: A PHASE II TRIAL OF VACCINATION WITH PEPTIDES FOR PATIENTS WITH
-
批准号:7718549
-
项目类别:
-
资助金额:$2.59万
-
财政年份:2008
-
负责人:Craig Lee Slingluff
-
依托单位:
EVALUATION OF CYCLOPHOSPHAMIDE WITH PEPTIDE VACCINES IN PARTICIPANTS W/MELANOMA
-
批准号:7718546
-
项目类别:
-
资助金额:$24.04万
-
财政年份:2008
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: EFFECTS OF LOCAL GM-CSF IN-ADJUVANT ON DENDRITIC CELLS IN MELANO
-
批准号:7718603
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:Craig Lee Slingluff
-
依托单位:
CLINICAL TRIAL: PHASE 2: CCI-779 IN COMBINATION WITH BEVACIZUMAB IN STAGE III OR
-
批准号:7718577
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:Craig Lee Slingluff
-
依托单位:
Targeted Molecular Therapeutics for Melanoma: CCI-779 and Bevacizumab
-
批准号:7275879
-
项目类别:
-
资助金额:$30.38万
-
财政年份:2007
-
负责人:Craig Lee Slingluff
-
依托单位:
SYNTHETIC HELPER PEPTIDE VACCINES FOR PATIENTS WITH STAGE IV MELANOMA
-
批准号:7606671
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2007
-
负责人:Craig Lee Slingluff
-
依托单位: